MENU

Gilead Sciences Aktie (NASDAQ:GILD)

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide.

{{ formattedPrice }} {{ change }} (-1,27 %)

Quotes delayed. Last trade: 22-10-2018, 10:00:00pm CEST

GILD vs. S&P 500
Eröffnung {{ openPrice }} Schlusskurs {{ closePrice }}
Tages-Hoch {{ high }} Tages-Tief {{ low }}
Geld {{ bid }} Brief {{ ask }}
Volumen 5281467    

Related Articles